{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T16:06:07Z","timestamp":1783008367134,"version":"3.54.5"},"reference-count":90,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,2,1]]},"DOI":"10.1093\/europace\/euw279","type":"journal-article","created":{"date-parts":[[2017,2,8]],"date-time":"2017-02-08T03:28:44Z","timestamp":1486524524000},"page":"169-179","source":"Crossref","is-referenced-by-count":95,"title":["Atrial high-rate episodes and stroke prevention"],"prefix":"10.1093","volume":"19","author":[{"given":"A. John","family":"Camm","sequence":"first","affiliation":[{"name":"Department of Clinical Cardiology, St George's University of London, London SW17 0RE, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Simantirakis","sequence":"additional","affiliation":[{"name":"Cardiology Department, Heraklion University Hospital, 71110 Voutes, Heraklion, Crete, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Goette","sequence":"additional","affiliation":[{"name":"Chief of Cardiology and Intensive Care Medicine, St. Vincenz-Hospital Paderborn, Paderborn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory Y.H.","family":"Lip","sequence":"additional","affiliation":[{"name":"University of Birmingham, Centre for Cardiovascular Sciences, City Hospital, Birmingham, UK"},{"name":"Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panos","family":"Vardas","sequence":"additional","affiliation":[{"name":"Cardiology Department, Heraklion University Hospital, 71110 Voutes, Heraklion, Crete, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Calvert","sequence":"additional","affiliation":[{"name":"Institute of Applied Health Research, University of Birmingham, Birmingham B15 2TT, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Chlouverakis","sequence":"additional","affiliation":[{"name":"Biostatistics Lab, School of Medicine, University of Crete, Crete, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Christoph","family":"Diener","sequence":"additional","affiliation":[{"name":"Department of Neurology, University Hospital Essen, Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulus","family":"Kirchhof","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Sciences, University of Birmingham, SWBH and UHB NHS Trusts, Birmingham, UK"},{"name":"Department of Cardiovascular Medicine, Hospital of the University of M\u00fcnster, M\u00fcnster, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,10,4]]},"reference":[{"key":"key\n\t\t\t\t20180222001233_euw279C1","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/S0140-6736(95)92339-X","article-title":"Does atrial fibrillation confer a hypercoagulable state?","volume":"346","author":"Lip","year":"1995","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180222001233_euw279C2","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","article-title":"Atrial fibrillation as an independent risk factor for stroke: the Framingham Study","volume":"22","author":"Wolf","year":"1991","journal-title":"Stroke"},{"key":"key\n\t\t\t\t20180222001233_euw279C3","author":"WHO"},{"key":"key\n\t\t\t\t20180222001233_euw279C4","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1161\/01.STR.32.2.392","article-title":"Characteristics, outcome, and care of stroke associated with atrial fibrillation in Europe: data from a multicenter multinational hospital-based registry (The European Community Stroke Project)","volume":"32","author":"Lamassa","year":"2001","journal-title":"Stroke"},{"key":"key\n\t\t\t\t20180222001233_euw279C5","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.ehj.2004.06.014","article-title":"Suppression of paroxysmal atrial tachyarrhythmias \u2013 results of the SOPAT trial","volume":"25","author":"Patten","year":"2004","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180222001233_euw279C6","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1023\/A:1009823001707","article-title":"Clinical relevance of silent atrial fibrillation: prevalence, prognosis, quality of life, and management","volume":"4","author":"Savelieva","year":"2000","journal-title":"J Intervent Card Electrophysiol"},{"key":"key\n\t\t\t\t20180222001233_euw279C7","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1161\/01.CIR.89.1.224","article-title":"Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia","volume":"89","author":"Page","year":"1994","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180222001233_euw279C8","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1093\/europace\/eus305","article-title":"2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation \u2013 developed with the special contribution of the European Heart Rhythm Association","volume":"14","author":"Camm","year":"2012","journal-title":"Europace"},{"key":"key\n\t\t\t\t20180222001233_euw279C9","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa1105575","article-title":"Subclinical atrial fibrillation and the risk of stroke","volume":"366","author":"Healey","year":"2012","journal-title":"N Engl J Med"},{"issue":"(4 Pt 1)","key":"key\n\t\t\t\t20180222001233_euw279C10","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1046\/j.1460-9592.2001.00424.x","article-title":"Clinical utility of intraatrial pacemaker stored electrograms to diagnose atrial fibrillation and flutter","volume":"24","author":"Pollak","year":"2001","journal-title":"Pacing Clin Electrophysiol"},{"key":"key\n\t\t\t\t20180222001233_euw279C11","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jacc.2014.10.052","article-title":"Benefit of anticoagulation unlikely in patients with atrial fibrillation and a CHA2DS2-VASc score of 1","volume":"65","author":"Friberg","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180222001233_euw279C12","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/j.1445-5994.2008.01878.x","article-title":"Atrial fibrillation and anticoagulation in a stroke unit population","volume":"39","author":"Ahmad","year":"2009","journal-title":"Intern Med J"},{"key":"key\n\t\t\t\t20180222001233_euw279C13","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000255973","article-title":"Stroke associated with atrial fibrillation \u2013 incidence and early outcomes in the north Dublin population stroke study","volume":"29","author":"Hannon","year":"2010","journal-title":"Cerebrovasc Dis"},{"key":"key\n\t\t\t\t20180222001233_euw279C14","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1468-1331.2012.03804.x","article-title":"Stroke due to atrial fibrillation in a population-based stroke registry (Ludwigshafen Stroke Study) CHADS(2), CHA(2) DS(2) -VASc score, underuse of oral anticoagulation, and implications for preventive measures","volume":"20","author":"Palm","year":"2013","journal-title":"Eur J Neurol"},{"key":"key\n\t\t\t\t20180222001233_euw279C15","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1093\/eurheartj\/ehs253","article-title":"2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association","volume":"33","author":"Camm","year":"2012","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180222001233_euw279C16","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1093\/europace\/euv068","article-title":"Non-vitamin K antagonist oral anticoagulants and atrial fibrillation guidelines in practice: barriers to and strategies for optimal implementation","volume":"17","author":"Camm","year":"2015","journal-title":"Europace"},{"key":"key\n\t\t\t\t20180222001233_euw279C17","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/europace\/eut263","article-title":"Management of atrial fibrillation in seven European countries after the publication of the 2010 ESC Guidelines on atrial fibrillation: primary results of the PREvention oF thromboemolic events \u2013 European Registry in Atrial Fibrillation (PREFER in AF)","volume":"16","author":"Kirchhof","year":"2014","journal-title":"Europace"},{"key":"key\n\t\t\t\t20180222001233_euw279C18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/europace\/eut270","article-title":"\u2018Preferred\u2019 management of atrial fibrillation in Europe","volume":"16","author":"Savelieva","year":"2014","journal-title":"Europace"},{"key":"key\n\t\t\t\t20180222001233_euw279C19","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180222001233_euw279C20","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1056\/NEJMoa1007432","article-title":"Apixaban in patients with atrial fibrillation","volume":"364","author":"Connolly","year":"2011","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180222001233_euw279C21","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180222001233_euw279C22","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180222001233_euw279C23","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","article-title":"Edoxaban versus warfarin in patients with atrial fibrillation","volume":"369","author":"Giugliano","year":"2013","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180222001233_euw279C24","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1540-8159.1998.tb01098.x","article-title":"Prevalence of supraventricular arrhythmias from the automated analysis of data stored in the DDD pacemakers of 617 patients: the AIDA study. The AIDA Multicenter Study Group. Automatic Interpretation for Diagnosis Assistance","volume":"21","author":"Defaye","year":"1998","journal-title":"Pacing Clin Electrophysiol"},{"key":"key\n\t\t\t\t20180222001233_euw279C25","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1093\/europace\/euv310","article-title":"How are arrhythmias detected by implanted cardiac devices managed in Europe? Results of the European Heart Rhythm Association Survey","volume":"17","author":"Todd","year":"2015","journal-title":"Europace"},{"key":"key\n\t\t\t\t20180222001233_euw279C26","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.ahj.2004.06.032","article-title":"Asymptomatic atrial fibrillation: demographic features and prognostic information from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study","volume":"149","author":"Flaker","year":"2005","journal-title":"Am Heart J"},{"key":"key\n\t\t\t\t20180222001233_euw279C27","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1161\/STROKEAHA.112.654954","article-title":"Continuous stroke unit electrocardiographic monitoring versus 24-hour Holter electrocardiography for detection of paroxysmal atrial fibrillation after stroke","volume":"43","author":"Rizos","year":"2012","journal-title":"Stroke"},{"key":"key\n\t\t\t\t20180222001233_euw279C28","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.1161\/STROKEAHA.113.001884","article-title":"Improved detection of silent atrial fibrillation using 72-hour Holter ECG in patients with ischemic stroke: a prospective multicenter cohort study","volume":"44","author":"Grond","year":"2013","journal-title":"Stroke"},{"key":"key\n\t\t\t\t20180222001233_euw279C29","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1056\/NEJMoa1313600","article-title":"Cryptogenic stroke and underlying atrial fibrillation","volume":"370","author":"Sanna","year":"2014","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180222001233_euw279C30","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1056\/NEJMoa1311376","article-title":"Atrial fibrillation in patients with cryptogenic stroke","volume":"370","author":"Gladstone","year":"2014","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180222001233_euw279C31","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1093\/europace\/eur431","article-title":"Improved screening for silent atrial fibrillation after ischaemic stroke","volume":"14","author":"Doliwa Sobocinski","year":"2012","journal-title":"Europace"},{"key":"key\n\t\t\t\t20180222001233_euw279C32","article-title":"Cryptogenic ischemic stroke and prevalence of asymptomatic atrial fibrillation: a prospective study","author":"Jorfida","year":"2014","journal-title":"J Cardiovasc Med"},{"key":"key\n\t\t\t\t20180222001233_euw279C33","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1161\/STROKEAHA.109.570382","article-title":"Prevalence and predictors of paroxysmal atrial fibrillation on Holter monitor in patients with stroke or transient ischemic attack","volume":"41","author":"Alhadramy","year":"2010","journal-title":"Stroke"},{"key":"key\n\t\t\t\t20180222001233_euw279C34","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1212\/01.wnl.0000325059.86313.31","article-title":"Atrial fibrillation detected by mobile cardiac outpatient telemetry in cryptogenic TIA or stroke","volume":"71","author":"Tayal","year":"2008","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20180222001233_euw279C35","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1161\/01.CIR.0000109490.72104.EE","article-title":"Canadian trial of physiological pacing: effects of physiological pacing during long-term follow-up","volume":"109","author":"Kerr","year":"2004","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180222001233_euw279C36","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0735-1097(01)01326-2","article-title":"Progression to chronic atrial fibrillation after pacing: the Canadian Trial of Physiologic Pacing. CTOPP Investigators","volume":"38","author":"Skanes","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180222001233_euw279C37","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1161\/01.CIR.0000057981.70380.45","article-title":"Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke: report of the Atrial Diagnostics Ancillary Study of the MOde Selection Trial (MOST)","volume":"107","author":"Glotzer","year":"2003","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180222001233_euw279C38","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1161\/CIRCEP.109.849638","article-title":"The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: the TRENDS study","volume":"2","author":"Glotzer","year":"2009","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"key\n\t\t\t\t20180222001233_euw279C39","first-page":"1351","article-title":"Subclinical atrial fibrillation and the risk of stroke","volume":"366","author":"Wiesel","year":"2012","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180222001233_euw279C40","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.amjcard.2008.03.080","article-title":"Frequency, duration, and predictors of newly-diagnosed atrial fibrillation following dual-chamber pacemaker implantation in patients without a previous history of atrial fibrillation","volume":"102","author":"Mittal","year":"2008","journal-title":"Am J Cardiol"},{"issue":"(10_S)A314","key":"key\n\t\t\t\t20180222001233_euw279C41","article-title":"et al. Paroxysmal atrial fibrillation poses a large but transient increase in ischemic stroke risk: a case crossover study","volume":"65","author":"Singer","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180222001233_euw279C42","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.amjmed.2014.11.026","article-title":"Asymptomatic atrial fibrillation: clinical correlates, management, and outcomes in the EORP-AF Pilot General Registry","volume":"128","author":"Boriani","year":"2015","journal-title":"Am J Med"},{"key":"key\n\t\t\t\t20180222001233_euw279C43","doi-asserted-by":"crossref","first-page":"4744","DOI":"10.1016\/j.ijcard.2013.07.234","article-title":"A comparison of clinical characteristics and long-term prognosis in asymptomatic and symptomatic patients with first-diagnosed atrial fibrillation: the Belgrade Atrial Fibrillation Study","volume":"168","author":"Potpara","year":"2013","journal-title":"Int J Cardiol"},{"key":"key\n\t\t\t\t20180222001233_euw279C44","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1093\/eurheartj\/eht491","article-title":"Device-detected atrial fibrillation and risk for stroke: an analysis of >10,000 patients from the SOS AF project (Stroke preventiOn Strategies based on Atrial Fibrillation information from implanted devices)","volume":"35","author":"Boriani","year":"2014","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180222001233_euw279C45","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1093\/europace\/euu267","article-title":"Silent ischaemic brain lesions related to atrial high rate episodes in patients with cardiac implantable electronic devices","volume":"17","author":"Benezet-Mazuecos","year":"2015","journal-title":"Europace"},{"key":"key\n\t\t\t\t20180222001233_euw279C46","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1016\/j.hrthm.2014.08.019","article-title":"Newly detected atrial high rate episodes predict long-term mortality outcomes in patients with permanent pacemakers","volume":"11","author":"Gonzalez","year":"2014","journal-title":"Heart Rhythm"},{"key":"key\n\t\t\t\t20180222001233_euw279C47","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1055\/s-0037-1617102","article-title":"The endothelium and atrial fibrillation. The prothrombotic state revisited","volume":"28","author":"Freestone","year":"2008","journal-title":"Hamostaseologie"},{"key":"key\n\t\t\t\t20180222001233_euw279C48","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/europace\/eur002","article-title":"Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention","volume":"13","author":"Savelieva","year":"2011","journal-title":"Europace"},{"key":"key\n\t\t\t\t20180222001233_euw279C49","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1016\/j.jacc.2012.04.063","article-title":"Inflammation in atrial fibrillation","volume":"60","author":"Guo","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180222001233_euw279C50","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1093\/europace\/eur023","article-title":"Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part II: secondary prevention","volume":"13","author":"Savelieva","year":"2011","journal-title":"Europace"},{"key":"key\n\t\t\t\t20180222001233_euw279C51","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1378\/chest.126.3.687","article-title":"Prothrombotic activity is increased in patients with nonvalvular atrial fibrillation and risk factors for embolism","volume":"126","author":"Inoue","year":"2004","journal-title":"Chest"},{"key":"key\n\t\t\t\t20180222001233_euw279C52","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0140-6736(09)60040-4","article-title":"Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited","volume":"373","author":"Watson","year":"2009","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180222001233_euw279C53","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1067\/mhj.2000.110284","article-title":"Atrial endocardial changes in mitral valve disease: a scanning electron microscopy study","volume":"140","author":"Goldsmith","year":"2000","journal-title":"Am Heart J"},{"key":"key\n\t\t\t\t20180222001233_euw279C54","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1161\/CIRCULATIONAHA.113.007825","article-title":"Temporal relationship between subclinical atrial fibrillation and embolic events","volume":"129","author":"Brambatti","year":"2014","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180222001233_euw279C55","author":"Botto"},{"key":"key\n\t\t\t\t20180222001233_euw279C56","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1161\/STROKEAHA.114.004800","article-title":"Mechanical discordance of the left atrium and appendage: a novel mechanism of stroke in paroxysmal atrial fibrillation","volume":"45","author":"Warraich","year":"2014","journal-title":"Stroke"},{"issue":"(2 Suppl.)","key":"key\n\t\t\t\t20180222001233_euw279C57","doi-asserted-by":"crossref","first-page":"e531S","DOI":"10.1378\/chest.11-2304","article-title":"Antithrombotic therapy for atrial fibrillation: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"You","year":"2012","journal-title":"Chest"},{"key":"key\n\t\t\t\t20180222001233_euw279C58","doi-asserted-by":"crossref","first-page":"615","DOI":"10.7326\/0003-4819-126-8-199704150-00005","article-title":"Risk for clinical thromboembolism associated with conversion to sinus rhythm in patients with atrial fibrillation lasting less than 48 hours","volume":"126","author":"Weigner","year":"1997","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t20180222001233_euw279C59","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.hrthm.2011.04.022","article-title":"Temporal relationship of atrial tachyarrhythmias, cerebrovascular events, and systemic emboli based on stored device data: a subgroup analysis of TRENDS","volume":"8","author":"Daoud","year":"2011","journal-title":"Heart Rhythm"},{"key":"key\n\t\t\t\t20180222001233_euw279C60","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1093\/europace\/eur293","article-title":"Detection of atrial high-rate events by continuous home monitoring: clinical significance in the heart failure-cardiac resynchronization therapy population","volume":"14","author":"Shanmugam","year":"2012","journal-title":"Europace"},{"key":"key\n\t\t\t\t20180222001233_euw279C61","first-page":"2792","article-title":"Clinical implications of device-detected atrial tachyarrhythmias: results from the Registry of Atrial Tachycardia and Atrial Fibrillation Episodes in the Cardiac Rhythm Management Device Population (RATE)","volume":"126","author":"Swiryn","year":"2012","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180222001233_euw279C62","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.cjca.2012.08.019","article-title":"Pacemaker-detected atrial fibrillation in patients with pacemakers: prevalence, predictors, and current use of oral anticoagulation","volume":"29","author":"Healey","year":"2013","journal-title":"Can J Cardiol"},{"key":"key\n\t\t\t\t20180222001233_euw279C63","first-page":"519","article-title":"Do patients with pacemaker-detected atrial fibrillation receive appropriate anticoagulation? 2011","volume":"13","author":"Anderson","year":"2011","journal-title":"Europace"},{"key":"key\n\t\t\t\t20180222001233_euw279C64","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0735-1097(99)00489-1","article-title":"Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy. Stroke Prevention in Atrial Fibrillation Investigators","volume":"35","author":"Hart","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180222001233_euw279C65","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1161\/STROKEAHA.113.003433","article-title":"Detection of atrial fibrillation after ischemic stroke or transient ischemic attack: a systematic review and meta-analysis","volume":"45","author":"Kishore","year":"2014","journal-title":"Stroke"},{"key":"key\n\t\t\t\t20180222001233_euw279C66","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180222001233_euw279C67","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1111\/pace.12428","article-title":"Atrial high rate episodes in patients with dual-chamber cardiac implantable electronic devices: unmasking silent atrial fibrillation","volume":"37","author":"Benezet-Mazuecos","year":"2014","journal-title":"Pacing Clin Electrophysiol"},{"key":"key\n\t\t\t\t20180222001233_euw279C68","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jacc.2014.10.045","article-title":"Device-detected atrial fibrillation: what to do with asymptomatic patients?","volume":"65","author":"Chen-Scarabelli","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180222001233_euw279C69","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ccl.2013.11.001","article-title":"Does atrial fibrillation detected by cardiac implantable electronic devices have clinical relevance?","volume":"32","author":"Glotzer","year":"2014","journal-title":"Cardiol Clin"},{"key":"key\n\t\t\t\t20180222001233_euw279C70","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euw295","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS: The Task Force for the management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESCEndorsed by the European Stroke Organisation (ESO)","author":"Kirchhof","year":"2016","journal-title":"Europace"},{"key":"key\n\t\t\t\t20180222001233_euw279C71","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/europace\/eur241","article-title":"Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options \u2013 a report from the 3rd Atrial Fibrillation Competence NETwork\/European Heart Rhythm Association consensus conference","volume":"14","author":"Kirchhof","year":"2012","journal-title":"Europace"},{"key":"key\n\t\t\t\t20180222001233_euw279C72","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1161\/CIRCULATIONAHA.110.937409","article-title":"Efficacy and safety of automatic remote monitoring for implantable cardioverter-defibrillator follow-up: the Lumos-T Safely Reduces Routine Office Device Follow-up (TRUST) trial","volume":"122","author":"Varma","year":"2010","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180222001233_euw279C73","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1093\/eurheartj\/ehv115","article-title":"Randomized trial of atrial arrhythmia monitoring to guide anticoagulation in patients with implanted defibrillator and cardiac resynchronization devices","volume":"36","author":"Martin","year":"2015","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180222001233_euw279C74","article-title":"Rhythm Evaluation for AntiCoagulaTion with COntinuous Monitoring (REACT COM)","author":"NCT01706146"},{"key":"key\n\t\t\t\t20180222001233_euw279C75","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10840-010-9485-5","article-title":"Unexpected low prevalence of atrial fibrillation in cryptogenic ischemic stroke: a prospective study","volume":"28","author":"Dion","year":"2010","journal-title":"J Intervent Card Electrophysiol"},{"key":"key\n\t\t\t\t20180222001233_euw279C76","first-page":"437","article-title":"Risk factors for atrial fibrillation: not always severe heart disease, not always so \u2018lonely","volume":"17","author":"Rosiak","year":"2010","journal-title":"Cardiol J"},{"key":"key\n\t\t\t\t20180222001233_euw279C77","first-page":"1351","article-title":"Subclinical atrial fibrillation and the risk of stroke","volume":"366","author":"Chiti","year":"2012","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180222001233_euw279C78","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1093\/europace\/euv083","article-title":"Cost-effectiveness of mass screening for untreated atrial fibrillation using intermittent ECG recording","volume":"17","author":"Aronsson","year":"2015","journal-title":"Europace"},{"key":"key\n\t\t\t\t20180222001233_euw279C79","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/ijcp.12304","article-title":"Biomarkers in atrial fibrillation: an overview","volume":"68","author":"Vilchez","year":"2014","journal-title":"Int J Clin Pract"},{"key":"key\n\t\t\t\t20180222001233_euw279C80","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/europace\/euv304","article-title":"A roadmap to improve the quality of atrial fibrillation management: proceedings from the fifth Atrial Fibrillation Network\/European Heart Rhythm Association consensus conference","volume":"18","author":"Kirchhof","year":"2016","journal-title":"Europace"},{"key":"key\n\t\t\t\t20180222001233_euw279C81","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ijcard.2007.06.020","article-title":"Accumulation of risk factors enhances the prothrombotic state in atrial fibrillation","volume":"126","author":"Ohara","year":"2008","journal-title":"Int J Cardiol"},{"key":"key\n\t\t\t\t20180222001233_euw279C82","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1161\/01.STR.0000236840.00467.84","article-title":"Additive role of plasma von Willebrand factor levels to clinical factors for risk stratification of patients with atrial fibrillation","volume":"37","author":"Lip","year":"2006","journal-title":"Stroke"},{"key":"key\n\t\t\t\t20180222001233_euw279C83","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1093\/eurheartj\/eht024","article-title":"Biomarkers in atrial fibrillation: a clinical review","volume":"34","author":"Hijazi","year":"2013","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180222001233_euw279C84","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1161\/CIRCULATIONAHA.111.038729","article-title":"Cardiac biomarkers are associated with an increased risk of stroke and death in patients with atrial fibrillation: a Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY) substudy","volume":"125","author":"Hijazi","year":"2012","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180222001233_euw279C85","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/joim.12478","article-title":"The changing circumstance of atrial fibrillation \u2013 progress towards precision medicine","volume":"279","author":"Camm","year":"2016","journal-title":"J Intern Med"},{"key":"key\n\t\t\t\t20180222001233_euw279C86","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1540-8167.2008.01320.x","article-title":"Presence and duration of atrial fibrillation detected by continuous monitoring: crucial implications for the risk of thromboembolic events","volume":"20","author":"Botto","year":"2009","journal-title":"J Cardiovasc Electrophysiol"},{"key":"key\n\t\t\t\t20180222001233_euw279C87","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1161\/STROKEAHA.110.609297","article-title":"Improving stroke risk stratification using the CHADS2 and CHA2DS2-VASc risk scores in patients with paroxysmal atrial fibrillation by continuous arrhythmia burden monitoring","volume":"42","author":"Boriani","year":"2011","journal-title":"Stroke"},{"key":"key\n\t\t\t\t20180222001233_euw279C88","article-title":"Apixaban for the Reduction of Thrombo-Embolism in Patients with Device-Detected Sub-Clinical Atrial Fibrillation (ARTESiA)","author":"NCT01938248"},{"key":"key\n\t\t\t\t20180222001233_euw279C89","article-title":"Non-vitamin K Antagonist Oral Anticoagulants in Patients with Atrial High Rate Episodes (NOAH)"},{"key":"key\n\t\t\t\t20180222001233_euw279C90","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.hrthm.2016.03.013","article-title":"Atrial electrograms improve the accuracy of tachycardia interpretation from ICD and pacemaker recordings: The RATE Registry","volume":"13","author":"Orlov","year":"2016","journal-title":"Heart Rhythm"}],"container-title":["EP Europace"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/europace\/article-pdf\/19\/2\/169\/24119846\/euw279.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T11:27:38Z","timestamp":1568806058000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/europace\/article\/19\/2\/169\/2952427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,4]]},"references-count":90,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2016,10,4]]},"published-print":{"date-parts":[[2017,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/europace\/euw279","relation":{},"ISSN":["1099-5129","1532-2092"],"issn-type":[{"value":"1099-5129","type":"print"},{"value":"1532-2092","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,2,1]]},"published":{"date-parts":[[2016,10,4]]}}}